The Prostate Net Regional Prostate Cancer Symposium Series  An Educational Initiative for Patients and Healthcare Professionals  May - October, 2010  An Educational Initiative for Patients and Healthcare Professionals  May - October, 2010

National Healthcare Quality Report “Preventive healthcare lags significantly behind other gains in healthcare.” Access to care and information varied widely between racial/ethnic groups and by socio-economic status Source: “Preventive healthcare lags significantly behind other gains in healthcare.” Access to care and information varied widely between racial/ethnic groups and by socio-economic status Source:

Concept  Provide access to information and thought leaders to promote best standards of care  dual-track format to maximize interaction  Provide a faculty of world-class clinicians and researchers who set the standards of care  Provide access to information and thought leaders to promote best standards of care  dual-track format to maximize interaction  Provide a faculty of world-class clinicians and researchers who set the standards of care

Meeting Objectives  Patients:  understand role of biomarkers of diagnosis/progression  describe current treatments and emerging drug protocols  discuss the importance of effective patient/doctor dialogues  Professionals:  identify best standards of care  Define the impact of treatment on co-morbid conditions  Discuss the advances in therapeutic and drug protocols  Describe the appropriate use of novel therapies  Evaluate the information’s applicability to practice management  Patients:  understand role of biomarkers of diagnosis/progression  describe current treatments and emerging drug protocols  discuss the importance of effective patient/doctor dialogues  Professionals:  identify best standards of care  Define the impact of treatment on co-morbid conditions  Discuss the advances in therapeutic and drug protocols  Describe the appropriate use of novel therapies  Evaluate the information’s applicability to practice management

Secondary Regional Goals  Rutgers: Impact of Healthcare Reform on Public Health Policy  Georgetown: Support for Pca Research Funding  Clark Atlanta: Minority Population Epidemiological and Clinical Research  University of Florida: Global Prostate Cancer Impact on Black Men  Northwestern: SPORE Research Expansion  New York: Total Spectrum of Disease Management  Rutgers: Impact of Healthcare Reform on Public Health Policy  Georgetown: Support for Pca Research Funding  Clark Atlanta: Minority Population Epidemiological and Clinical Research  University of Florida: Global Prostate Cancer Impact on Black Men  Northwestern: SPORE Research Expansion  New York: Total Spectrum of Disease Management

Listening to the Audience: ARS initiative In all Symposia an interactive individual computer polling device is used to measure audience demographics and responses to key “Need to Know” questions

Rutgers Symposium Agenda

Registered Attendance  Patients/spouses, Advocates, Caregivers  On-Site: 81  Patients - 64  Caregivers - 17  Follow-on distribution - 202:  Through NJ OCCP Coordinator Training, Gilda’s Club, ACS  Barbershop Initiative/NJCEED educational sessions - 73  Professionals  Doctors: On-Site  Medoncs - 16  Radoncs - 8  Primary Care - 13  Urologists - 6  Public Health Agencies On-Site:  Physicians and medical assistants - 9  Community outreach workers - 7  Follow-on distribution - 38:  RadOncs - 3; NP/PAs - 8  Medical Centers/Public health agencies - 27  Patients/spouses, Advocates, Caregivers  On-Site: 81  Patients - 64  Caregivers - 17  Follow-on distribution - 202:  Through NJ OCCP Coordinator Training, Gilda’s Club, ACS  Barbershop Initiative/NJCEED educational sessions - 73  Professionals  Doctors: On-Site  Medoncs - 16  Radoncs - 8  Primary Care - 13  Urologists - 6  Public Health Agencies On-Site:  Physicians and medical assistants - 9  Community outreach workers - 7  Follow-on distribution - 38:  RadOncs - 3; NP/PAs - 8  Medical Centers/Public health agencies - 27

Lombardi/Congressional Symposium

Registered Attendance  On-Site - 93:  U.S. Congressman - 1  Congressional Legislative Staff - 26  Patients/Advocates - 25  Healthcare Professionals:  Medical Oncologists - 4  Urologists - 3  Cancer Researchers - 23  Pharmaceutical Industry - 7  Follow-up plans:  Meetings being scheduled with Congressional Members of:  Appropriations Committee  Ways and Means Committee  Partnering with Dept. of Defense Research Grantees to present evidence for increased research funding and preventive education programs  On-Site - 93:  U.S. Congressman - 1  Congressional Legislative Staff - 26  Patients/Advocates - 25  Healthcare Professionals:  Medical Oncologists - 4  Urologists - 3  Cancer Researchers - 23  Pharmaceutical Industry - 7  Follow-up plans:  Meetings being scheduled with Congressional Members of:  Appropriations Committee  Ways and Means Committee  Partnering with Dept. of Defense Research Grantees to present evidence for increased research funding and preventive education programs

Clark Atlanta Symposium

Registered Attendance  Patients/spouses, Advocates, Caregivers  On-Site: 68  Patients - 54  Advocates - 14  Follow-on distribution - 107:  Through Georgia Men’s Health Coalition  Prostate Net Barbershop Initiative™  Doctors: On-Site: 17  Medoncs - 8  Radoncs - 1  Primary Care - 0  Urologists - 8  Public Health Agencies On-Site: 59  Nurses and medical assistants - 22  Community outreach workers - 37  Cancer Researchers On-Site: 22  Center for Cancer Research and Therapeutic Development - 17  Morehouse School of Medicine - 3  Centers for Disease Control and Prevention - 2  Follow-on distribution - 56:  Urologists - 26  Medoncs - 3  RadOncs - 3  NP/PAs - 8  Medical Centers/Public health agencies - 16  Patients/spouses, Advocates, Caregivers  On-Site: 68  Patients - 54  Advocates - 14  Follow-on distribution - 107:  Through Georgia Men’s Health Coalition  Prostate Net Barbershop Initiative™  Doctors: On-Site: 17  Medoncs - 8  Radoncs - 1  Primary Care - 0  Urologists - 8  Public Health Agencies On-Site: 59  Nurses and medical assistants - 22  Community outreach workers - 37  Cancer Researchers On-Site: 22  Center for Cancer Research and Therapeutic Development - 17  Morehouse School of Medicine - 3  Centers for Disease Control and Prevention - 2  Follow-on distribution - 56:  Urologists - 26  Medoncs - 3  RadOncs - 3  NP/PAs - 8  Medical Centers/Public health agencies - 16

University of Florida Symposium

Northwestern Symposium

The Prostate Net Symposium October 2, 2010

On-Going Educational Reinforcement  Archives of all Symposium Presentations are accessible through an Information Portal at:  Data capture of viewer demographics for future targeting  Opportunity to poll database for response on key disease issues

Thank You!